We are live on
!
Find out more
ProShare Advisors Portfolio holdings
AUM
$67.5B
1-Year Est. Return
28.09%
This Quarter
Est. Return
+7.56%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$40.8B
AUM Growth
+$3.42B
(+9.2%)
Cap. Flow
+$1.07B
Cap. Flow
% of AUM
2.63%
Top 10 Holdings %
Top 10 Hldgs %
25.28%
Holding
2,151
New
303
Increased
1,108
Reduced
653
Closed
86
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
West Pharmaceutical
WST
|
+$197M |
| 2 |
Walmart Inc
WMT
|
+$193M |
| 3 |
NextEra Energy
NEE
|
+$177M |
| 4 |
Apple
AAPL
|
+$129M |
| 5 |
UnitedHealth
UNH
|
+$120M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Qualcomm
QCOM
|
+$230M |
| 2 |
Sysco
SYY
|
+$164M |
| 3 |
Synopsys
SNPS
|
+$81.2M |
| 4 |
C.H. Robinson
CHRW
|
+$53.8M |
| 5 |
United Bankshares
UBSI
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 29.01% |
| 2 | Consumer Staples | 11.62% |
| 3 | Industrials | 10.88% |
| 4 | Consumer Discretionary | 9.53% |
| 5 | Healthcare | 9.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
676
Fabrinet
FN
$17.1B
| $2M | ﹤0.01% |
8,468
+2,812
| +50% | +$651K |
|
677
Boston Properties
BXP
$11B
| $1.98M | ﹤0.01% |
24,660
-860
| -3% | -$61.6K |
|
678
Pinnacle West Capital
PNW
$12.9B
| $1.97M | ﹤0.01% |
22,284
-1,167
| -5% | -$99.7K |
|
679
Commault Systems
CVLT
$5.89B
| $1.9M | ﹤0.01% |
12,338
+1,575
| +15% | +$222K |
|
680
Fluor
FLR
$7.29B
| $1.9M | ﹤0.01% |
39,733
+12,542
| +46% | +$591K |
|
681
Evergy
EVRG
$20.1B
| $1.89M | ﹤0.01% |
30,550
-2,840
| -9% | -$165K |
|
682
MarketAxess Holdings
MKTX
$4.15B
| $1.86M | ﹤0.01% |
7,248
-4,475
| -38% | -$1.05M |
|
683
UFP Industries
UFPI
$4.97B
| $1.85M | ﹤0.01% |
14,092
-7,836
| -36% | -$946K |
|
684
Pool Corp
POOL
$6.7B
| $1.82M | ﹤0.01% |
4,829
-411
| -8% | -$142K |
|
685
BorgWarner
BWA
$13.2B
| $1.81M | ﹤0.01% |
49,740
-1,772
| -3% | -$58.4K |
|
686
American Airlines Group
AAL
$9.58B
| $1.79M | ﹤0.01% |
158,872
-33,446
| -17% | -$354K |
|
687
Cytokinetics
CYTK
$11B
| $1.78M | ﹤0.01% |
33,679
+7,112
| +27% | +$396K |
|
688
Lantheus
LNTH
$6.82B
| $1.76M | ﹤0.01% |
16,040
+3,654
| +30% | +$380K |
|
689
JB Hunt Transport Services
JBHT
$27.1B
| $1.76M | ﹤0.01% |
10,205
-1,052
| -9% | -$177K |
|
690
Revolution Medicines
RVMD
$40.2B
| $1.75M | ﹤0.01% |
38,664
+9,796
| +34% | +$427K |
|
691
Campbell Soup
CPB
$6.51B
| $1.73M | ﹤0.01% |
35,437
-17,116
| -33% | -$833K |
|
692
Mueller Industries
MLI
$14.1B
| $1.73M | ﹤0.01% |
46,694
+12,104
| +35% | +$405K |
|
693
SouthState Bank Corp
SSB
$10.3B
| $1.72M | ﹤0.01% |
17,695
+3,896
| +28% | +$356K |
|
694
Bio-Techne
TECH
$11.2B
| $1.72M | ﹤0.01% |
21,491
-1,679
| -7% | -$126K |
|
|
CTLT
695
DELISTED
CATALENT, INC.
CTLT
| $1.72M | ﹤0.01% |
28,325
-2,070
| -7% | -$122K |
|
|
PARA
696
DELISTED
Paramount Global Class B
PARA
| $1.71M | ﹤0.01% |
161,382
+17,564
| +12% | +$191K |
|
697
Taylor Morrison
TMHC
$6.67B
| $1.68M | ﹤0.01% |
23,881
+5,006
| +27% | +$321K |
|
698
Rambus
RMBS
$10.4B
| $1.67M | ﹤0.01% |
39,481
+5,010
| +15% | +$243K |
|
699
Match Group
MTCH
$8.84B
| $1.66M | ﹤0.01% |
43,899
-34,696
| -44% | -$1.21M |
|
700
Abercrombie & Fitch
ANF
$4.17B
| $1.64M | ﹤0.01% |
11,732
+4,169
| +55% | +$634K |
|
Similar funds
ProShare Advisors's Q3 2024 Portfolio in Review
As of Q3 2024, ProShare Advisors held 2,151 positions worth $40.8B, up 9.2% from $37.4B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
ProShare Advisors's Q3 2024 filing shows 303 new, 1,108 increased, 653 reduced and 86 closed positions. Its largest new stake was NexPoint Residential Trust: 319,514 shares worth $14.1M. The largest sale was Qualcomm, an estimated $230M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Consumer Staples and Industrials.
- ProShare Advisors's largest Q3 2024 buy was NexPoint Residential Trust: 319,514 shares worth $14.1M.
- ProShare Advisors added most to West Pharmaceutical in Q3 2024, an estimated $197M increase.
- ProShare Advisors's biggest Q3 2024 reduction was Qualcomm, cutting an estimated $230M.
- ProShare Advisors fully exited Atrion Corp in Q3 2024, selling an estimated $8.02M.
- ProShare Advisors's ten largest holdings make up 25% of its $40.8B portfolio in Q3 2024.
- ProShare Advisors opened 303 new positions and closed 86 in Q3 2024.
- ProShare Advisors's portfolio value rose 9.2% quarter-over-quarter to $40.8B.
Based on ProShare Advisors's 13F filing for Q3 2024, filed 14 Nov 2024.